Literature DB >> 9758575

Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori.

L Laine1, R Estrada, M Trujillo, K Knigge, M B Fennerty.   

Abstract

BACKGROUND: Proton-pump inhibitor therapy may cause false-negative results on Helicobacter pylori diagnostic testing.
OBJECTIVE: To determine the frequency and duration of conversion of urea breath test results from positive to negative in patients given a proton-pump inhibitor.
SETTING: Two urban university gastroenterology clinics. PATIENTS: Patients infected with H. pylori who had positive results on urea breath tests. INTERVENTION: Lansoprazole, 30 mg/d for 28 days. MEASUREMENTS: The urea breath test was repeated at 28 days. If the results were negative, testing was repeated 3, 7, 14, and 28 days after completion of therapy until the results reverted to positive.
RESULTS: 31 (33%) of 93 patients in whom H. pylori was not eradicated had a negative breath test result while receiving lansoprazole. The proportions of patients whose breath test results were positive after completion of lansoprazole therapy were 91% (95% CI, 83% to 96%) at 3 days, 97% (CI, 90% to 99%) at 7 days, and 100% (CI, 96% to 100%) at 14 days.
CONCLUSION: Patients should not receive proton-pump inhibitors for 2 weeks before receiving the urea breath test for H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758575     DOI: 10.7326/0003-4819-129-7-199810010-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  32 in total

1.  Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the 13C-Urea Breath Test in Helicobacter pylori-Positive Patients.

Authors:  Mayu Takimoto; Toshihiko Tomita; Takahisa Yamasaki; Shota Fukui; Masato Taki; Takuya Okugawa; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Eitatsu Arai; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  Dig Dis Sci       Date:  2017-01-12       Impact factor: 3.199

Review 2.  Diagnosis of Helicobacter pylori infection : A short review.

Authors:  Ante Tonkic; Jonatan Vukovic; Pavle Vrebalov Cindro; Valdi Pesutic Pisac; Marija Tonkic
Journal:  Wien Klin Wochenschr       Date:  2018-06-29       Impact factor: 1.704

3.  A review of current guidelines for the management of Helicobacter pylori infection in children and adolescents.

Authors:  Nicola L Jones
Journal:  Paediatr Child Health       Date:  2004-12       Impact factor: 2.253

Review 4.  The 13C urea breath test in the diagnosis of Helicobacter pylori infection.

Authors:  V Savarino; S Vigneri; G Celle
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

5.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

6.  Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test.

Authors:  Pietro Dulbecco; Camilla Gambaro; Claudio Bilardi; Patrizia Zentilin; Maria Raffaella Mele; Carlo Mansi; Riccardo Biagini; Laura Tessieri; Elena Iiritano; Paolo Usai; Sergio Vigneri; Vincenzo Savarino
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

7.  Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.

Authors:  Soumana C Nasser; Mahmoud Slim; Jeanette G Nassif; Selim M Nasser
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Follow up of serial urea breath test results in patients after consumption of antibiotics for non-gastric infections.

Authors:  Wai-Keung Leung; Lawrence Cheung-Tsui Hung; Carrie Ka-Li Kwok; Rupert Wing-Loong Leong; Daniel Kwok-Keung Ng; Joseph Jao-Yiu Sung
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis.

Authors:  Tomohiko Moriyama; Takayuki Matsumoto; Katsuya Hirakawa; Hirofumi Ikeda; Kazuhiko Tsuruya; Hideki Hirakata; Mitsuo Iida
Journal:  J Gastroenterol       Date:  2010-01-19       Impact factor: 7.527

Review 10.  Helicobacter pylori-negative, non-steroidal anti-inflammatory drug: negative idiopathic ulcers in Asia.

Authors:  Katsunori Iijima; Takeshi Kanno; Tomoyuki Koike; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.